Home/Pipeline/Glaucoma Treatment

Glaucoma Treatment

Glaucoma

CommercialActive

Key Facts

Indication

Glaucoma

Phase

Commercial

Status

Active

Company

BVI Medical

About BVI Medical

BVI Medical is a well-established, privately-held player in the global ophthalmic surgical device market. The company positions itself as one of the fastest-growing, diversified surgical ophthalmic businesses, leveraging a portfolio of trusted brands to address a wide range of eye conditions including cataracts, glaucoma, and retinal diseases. Its strategy emphasizes being agile and physician-focused, delivering innovative solutions based on direct clinical needs. With a commercial footprint spanning over 90 countries, BVI has a significant international presence and a broad product portfolio across multiple ophthalmic sub-specialties.

View full company profile

Therapeutic Areas

Ophthalmology

Other Glaucoma Drugs

Drug	Company	Phase	Status
PREZIA Glaucoma Implant	PolyActiva	Preclinical	Active
MIGS Device System	Micropoint Biotechnologies	Commercial	Market approved in China
INM-088	InMed Pharmaceuticals	Preclinical	Active
OT-401	Ocumension Therapeutics	Phase 2	Active
ANX007	Annexon Biosciences	Phase 2	Active
PER-001	Perfuse Therapeutics	Phase 2	Active
hOTX2	BrainEver	Discovery	Active
MediPrint Lens (Glaucoma)	MediPrint Ophthalmics	Phase 2b	Active
Glaucoma Program	Broadwing Bio	Pre-clinical	Active
MSC Exosomal Eye Serum	Vitti Labs	Pre-clinical	Active
BTQ1902	Betaliq	Phase 2	Active
TODDD™ Platform	Amorphex Therapeutics	Pre-clinical	Active